E

Entia Biosciences Inc
OTC:ERGO

Watchlist Manager
Entia Biosciences Inc
OTC:ERGO
Watchlist
Price: 0.0003 USD Market Closed
Market Cap: 10.1k USD

Gross Margin
Entia Biosciences Inc

65.5%
Current
61%
Average
31.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.5%
=
Gross Profit
174k
/
Revenue
265.5k

Gross Margin Across Competitors

No Stocks Found

Entia Biosciences Inc
Glance View

Market Cap
10.1k USD
Industry
Consumer products

Entia Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Sherwood, Oregon. The company went IPO on 2007-11-01. The firm also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The firm's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The firm's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

ERGO Intrinsic Value
Not Available
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.5%
=
Gross Profit
174k
/
Revenue
265.5k
What is the Gross Margin of Entia Biosciences Inc?

Based on Entia Biosciences Inc's most recent financial statements, the company has Gross Margin of 65.5%.

Back to Top